Cannabidiol-Loaded Lipid-Stabilized Nanoparticles Alleviate Psoriasis Severity in Mice: A New Approach for Improved Topical Drug Delivery
Molecules · 02.10.2023 · 28 (19) · 6907
DOI: 10.3390/molecules28196907 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 02.10.2023. Verfasst von Mark Zamansky und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Ben Gurion University of the Negev, Be'er Sheva 84105, Israel. Hauptthemen laut MEDLINE: Cannabidiol, Psoriasis, Nanoparticles. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cannabidiol (CBD) is a promising natural agent for treating psoriasis. CBD activity is attributed to inhibition of NF-kB, IL-1β, IL-6, and IL-17A. The present study evaluated the anti-psoriatic effect of cannabidiol in lipid-stabilized nanoparticles (LSNs) using an imiquimod (IMQ)-induced psoriasis model in mice. CBD-loaded LSNs were stabilized with three types of lipids, Cetyl alcohol (CA), Lauric acid (LA), and stearic-lauric acids (SALA), and were examined in-vitro using rat skin and in-vivo using the IMQ-model. LSNs loaded with coumarin-6 showed a localized penetration depth of about 100 µm into rat skin. The LSNs were assessed by the IMQ model accompanied by visual (psoriasis area severity index; PASI), histological, and pro-psoriatic IL-17A evaluations. Groups treated with CBD-loaded LSNs were compared to groups treated with CBD-containing emulsion, unloaded LSNs, and clobetasol propionate, and to an untreated group. CBD-loaded LSNs significantly reduced PASI scoring compared to the CBD emulsion, the unloaded LSNs, and the untreated group (negative controls). In addition, SALA- and CA-containing nanoparticles significantly inhibited IL-17A release, showing a differential response: SALA > CA > LA. The data confirms the effectiveness of CBD in psoriasis therapy and underscores LSNs as a promising platform for delivering CBD to the skin.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Ben Gurion University of the Negev, Be'er Sheva 84105, Israel.
- Laboratory for Biopharmaceutics, E.D. Bergmann Campus, Ben-Gurion University of the Negev, Be'er Sheva 84105, Israel.
- Department of Biochemistry and Pharmacology, Ben Gurion University of the Negev, Be'er Sheva 84105, Israel.
ORCID-Profile: Mark Zamansky, Shimon Ben-Shabat, Amnon C Sintov
Zitieren
APA
Zamansky, M., Yariv, D., Feinshtein, V., Ben-Shabat, S., & Sintov, A. C. (2023). Cannabidiol-Loaded Lipid-Stabilized Nanoparticles Alleviate Psoriasis Severity in Mice: A New Approach for Improved Topical Drug Delivery. Molecules, 28(19), 6907. https://doi.org/10.3390/molecules28196907
Vancouver
Zamansky M, Yariv D, Feinshtein V, Ben-Shabat S, Sintov AC. Cannabidiol-Loaded Lipid-Stabilized Nanoparticles Alleviate Psoriasis Severity in Mice: A New Approach for Improved Topical Drug Delivery. Molecules. 2023;28(19):6907. doi:10.3390/molecules28196907
BibTeX
@article{Zamansky2023,
author = {Zamansky, Mark and Yariv, Doron and Feinshtein, Valeria and Ben-Shabat, Shimon and Sintov, Amnon C},
title = {Cannabidiol-Loaded Lipid-Stabilized Nanoparticles Alleviate Psoriasis Severity in Mice: A New Approach for Improved Topical Drug Delivery},
journal = {Molecules},
year = {2023},
volume = {28},
number = {19},
pages = {6907},
doi = {10.3390/molecules28196907}
}
EUVIMED